Megan Brooks

Sixteen lots of clonazepam orally disintegrating tablets have been recalled because of a packaging error that could have life-threatening consequences.

How does regular consumption of coffee, tea, alcohol, and soda affect stroke risk? Here’s the latest data to help guide discussions with your patients.

Methadone has been shown to be highly effective for opioid use disorder. So why is it still so hard to prescribe in the United States and is that about to change?

Tenecteplase was shown to be superior to alteplase for acute ischemic stroke, with a greater chance of excellent recovery and reduced disability in an updated meta-analysis.

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and alcohol intoxication, a large real-world study suggested.

Lumryz is the only FDA-approved once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness in children as young as 7 years with narcolepsy.

A new study highlights the potential of using smartphone data collected in real-world situations for the early detection of cognitive decline in older adults.

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should you know about the drug's history…and promise?

The benefits of bariatric surgery on obesity-related cancer and cardiovascular disease seen in younger adults may not translate to older adults, a population-based cohort study concluded.

Researchers have published clinical criteria for a type of memory loss in older adults that progresses more slowly and has a better prognosis than Alzheimer’s disease.